113 results match your criteria: "Centre national de Référence Mycoses Invasives et Antifongiques[Affiliation]"

Dynamics of Histoplasma fungal load in people living with HIV with disseminated histoplasmosis under treatment with liposomal amphotericin B.

Clin Microbiol Infect

December 2024

Groupe de Recherche Mycologie Translationnelle, Département de Mycologie, Institut Pasteur, Université Paris Cité, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France; Laboratoire de Parasitologie-Mycologie, AP-HP, Département de biologie médicale, Hôpital Saint-Louis, Paris, France. Electronic address:

Objectives: Disseminated histoplasmosis (DH) is a lethal fungal disease in patients living with HIV in endemic regions of the world. Diagnosis relies mainly on microscopy, culture, and antigen detection. Our goal was to evaluate the diagnostic and prognostic role of our RT-quantitative PCR (RT-qPCR) in blood specimens allowing to quantify the whole nucleic acids (WNA) load.

View Article and Find Full Text PDF

Case report: osteo-articular infection in a patient with Chronic Granulomatous Disease.

Med Mycol Case Rep

December 2024

Université Paris Cité, Faculté de Médecine, APHP, Hôpital Necker Enfants malades, Service de Maladies Infectieuses et Tropicales, 149 rue de Sèvres, 75015, Paris, France.

is a recently reported yeast causing rare cases of fungemia. This species presents high minimum inhibitory concentrations (MICs) to fluconazole and echinocandins. We report an atypical metacarpophalangeal osteo-articular infection in a patient with Chronic Granulomatous Disease.

View Article and Find Full Text PDF

Reverse-transcriptase real-time PCR in the diagnostic strategy for invasive infections caused by .

J Clin Microbiol

November 2024

Hospices Civils de Lyon, Laboratoire de Parasitologie et Mycologie Médicale, Institut des Agents Infectieux, Lyon, France.

The aim was to develop an RT-qPCR targeting and compare its performance to that of qPCR for the diagnosis of invasive aspergillosis (IA). Samples from patients of the Lyon University hospitals for whom a suspicion of IA led to the realization of an qPCR molecular diagnostic test over a 2-year period were included. The patients were classified according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC-MSGERC) criteria for suspected IA; RT-qPCR and qPCR assays were performed on all included samples.

View Article and Find Full Text PDF

Introduction: Real-world data from multinational observational studies are required to better understand the role and performance of isavuconazole in real-world practice in Europe.

Methods: A retrospective medical record review was conducted at 16 sites in Europe (France, Germany, Italy, Spain, and the United Kingdom). Eligible records were from patients aged ≥ 18 years at the time of isavuconazole initiation and received at least one dose of isavuconazole for suspected or confirmed invasive aspergillosis (IA) or invasive mucormycosis (IM) during the eligibility period (October 15, 2015 to June 30, 2019).

View Article and Find Full Text PDF

Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes.

PLoS Negl Trop Dis

October 2024

Laboratório de Micologia, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Background: Auranofin is an approved anti-rheumatic drug that has a broad-range inhibitory action against several microorganisms, including human pathogenic fungi. The auranofin activity against Histoplasma capsulatum, the dimorphic fungus that causes histoplasmosis, has not been properly addressed. Since there are few therapeutic options for this life-threatening systemic mycosis, this study evaluated the effects of auranofin on H.

View Article and Find Full Text PDF
Article Synopsis
  • Prosthetic joint infections (PJIs) caused by Candida species are serious complications following joint replacement surgeries, with a study reviewing 269 cases between 2010 and 2021 to assess treatment outcomes.
  • The majority of infections occurred in older patients (average age 73), primarily in hips and knees, and most cases involved additional bacterial infections; roughly 58% achieved a cure at the two-year follow-up.
  • Treatment effectiveness varied significantly depending on the surgical method used, with poorer outcomes linked to the debridement, antibiotics, and implant retention (DAIR) approach and patients older than 70, while infections from Candida parapsilosis tended to have better outcomes.
View Article and Find Full Text PDF

Epidemiology, Clinical Manifestations, Treatment, and Outcome of Mucormycosis: A Review of 77 Cases From a Single Center in France.

Open Forum Infect Dis

August 2024

Department of Infectious Diseases, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.

Article Synopsis
  • - The study analyzed mucormycosis cases over 15 years at a French center, reviewing medical records and introducing qPCR for better diagnosis in 2015.
  • - A total of 77 patients were examined, primarily with hematological diseases, and common infection sites included the lungs and sinuses. Diagnosis was challenging, with qPCR aiding in 30% of cases.
  • - The overall survival rate was low at 40%, but combining surgical and antifungal treatments significantly improved patient outcomes, particularly for those with hematological issues and burns.
View Article and Find Full Text PDF

In Vitro Titan Cell Generation in Cryptococcus neoformans and Automated Cell Size Measurements.

Methods Mol Biol

May 2024

Translational Mycology Research Group, Institut Pasteur, Université Paris Cité, Centre National de Référence Mycoses Invasives et Antifongiques, Département de Mycologie, Paris, France.

A special feature of the human fungal pathogen Cryptococcus neoformans is its morphological changes triggered by the interaction with the host. During infection, a specific increase in cell size is observed, particularly in lung tissue, from a typical cell size of 5-7 μm cells to cells larger than 10 μm, dubbed titan cells (TCs). However, the study of this specific cell subpopulation was, until now, only possible via recovery of TCs from lungs of mice during experimental infections where stable and reproducible generation of TCs occurs.

View Article and Find Full Text PDF
Article Synopsis
  • - A new species of yeast called Trichosporon austroamericanum sp. nov. was identified during an epidemiological survey of a kidney transplant recipient from Brazil, based on a urine sample.
  • - The strain was characterized using molecular techniques, specifically the intergenic spacer (IGS1) ribosomal DNA locus, revealing its close relation to Trichosporon inkin but highlighting its uniqueness.
  • - T. austroamericanum can be differentiated from other related Trichosporon species through distinct morphological, physiological, and phylogenetic traits.
View Article and Find Full Text PDF

Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study.

Clin Microbiol Infect

June 2024

Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) de Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity) INSERM, Université Toulouse III, Toulouse, France. Electronic address:

Article Synopsis
  • Bispecific antibodies (BsAbs) are used to treat relapsed or refractory multiple myeloma, but frequent infections were noted during clinical trials, indicating a need for further real-world data on infection risks and outcomes.
  • A multicenter retrospective study involving 229 patients in France from December 2020 to February 2023 found a high incidence of infections, with 234 recorded cases, primarily affecting the respiratory system, and a hospitalization rate of 56%.
  • The study identified corticosteroids used for managing cytokine release syndrome as a risk factor for infections, while using GPRC5D-targeting BsAbs and antibacterial prophylaxis was associated with a reduced risk.
View Article and Find Full Text PDF

Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.

Lancet Infect Dis

August 2024

Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, USA; Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC, USA. Electronic address:

Cryptococcosis is a major worldwide disseminated invasive fungal infection. Cryptococcosis, particularly in its most lethal manifestation of cryptococcal meningitis, accounts for substantial mortality and morbidity. The breadth of the clinical cryptococcosis syndromes, the different patient types at-risk and affected, and the vastly disparate resource settings where clinicians practice pose a complex array of challenges.

View Article and Find Full Text PDF

Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study.

Lancet Microbe

March 2024

Institut Pasteur, Université Paris Cité, Translational Mycology Group, Centre National de Référence Mycoses Invasives et Antifongiques, Department of Mycology, Paris, France; Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France. Electronic address:

Article Synopsis
  • HIV-associated cryptococcal meningitis is a major cause of AIDS deaths, prompting research to establish a faster method for detecting fungal load, which traditionally relies on CFU counts.
  • The study developed qPCR assays to identify and quantify different Cryptococcus species in cerebrospinal fluid from patients in sub-Saharan Africa, analyzing samples at various stages of antifungal treatment.
  • Results showed high sensitivity in detecting fungal load and identified a significant prevalence of Cryptococcus neoformans in both Botswana and Malawi, with some patients showing viable but non-culturable yeasts after treatment.
View Article and Find Full Text PDF

[Pulmonary complications of Chronic Granulomatous Disease].

Rev Mal Respir

February 2024

Service de pneumologie, hôpital Foch, 40, rue Worth, 92150 Suresnes, France.

Chronic Granulomatosis Disease (CGD) is an inherited immune deficiency due to a mutation in the genes coding for the subunits of the NADPH oxidase enzyme that affects the oxidative capacity of phagocytic cells. It is characterized by increased susceptibility to bacterial and fungal infections, particularly Aspergillus, as well as complications associated with hyperinflammation and granulomatous tissue infiltration. There exist two types of frequently encountered pulmonary manifestations: (1) due to their being initially pauci-symptomatic, possibly life-threatening infectious complications are often discovered at a late stage.

View Article and Find Full Text PDF

Performance of clinical metagenomics in France: a prospective observational study.

Lancet Microbe

January 2024

Microbiology Department, AP-HP, Hôpital Necker, Paris, France; Université Paris Cité, CNRS, INSERM, Institut Necker-Enfants Malades, Team Pathogenesis of Systemic Infection, Paris, France. Electronic address:

Background: Metagenomic next-generation sequencing (mNGS) allows untargeted identification of a broad range of pathogens, including rare or novel microorganisms. Despite the recognition of mNGS as a valuable diagnostic tool for infections, the most relevant indications for this innovative strategy remain poorly defined. We aimed to assess the determinants of positivity and clinical utility of mNGS.

View Article and Find Full Text PDF

Primary intestinal lymphangiectasia (Waldmann's disease) is a rare exudative enteropathy without precisely assessed infectious risk. We report the case of a 49-year-old male patient with meningitis and cerebral vasculitis due to Cryptococcus neoformans complicating Waldmann's disease diagnosed 12 years ago. The treatment combined liposomal amphotericin B, 3 mg/kg daily plus flucytosine 25 mg/kg/6 h, both intravenously during 15 days, then fluconazole 800 mg daily during 8 weeks, and finally 200 mg daily indefinitely.

View Article and Find Full Text PDF

Candida haemulonii complex, an emerging threat from tropical regions?

PLoS Negl Trop Dis

July 2023

Centre National de Référence des Mycoses invasives et Antifongiques, Département de Mycologie, Institut Pasteur, Université de Paris Cité, Paris, France.

Background: Candida haemulonii complex-related species are pathogenic yeasts closely related to Candida auris with intrinsic antifungal resistance, but few epidemiological data are available.

Methodology/principal Findings: We analyzed clinical and demographic characteristics of patients with fungemia due to C. haemulonii complex and related species (C.

View Article and Find Full Text PDF

Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.

Med Mycol

July 2023

Institut Pasteur, Centre National de Référence Mycoses Invasives et Antifongiques, Groupe de recherche Mycologie Translationnelle, Département de Mycologie, Université Paris Cité, Paris, France.

The (1→3)-β-D-glucan (BDG) is a component of the fungal cell wall that can be detected in serum and used as an adjunctive tool for the diagnosis of invasive mold infections (IMI) in patients with hematologic cancer or other immunosuppressive conditions. However, its use is limited by modest sensitivity/specificity, inability to differentiate between fungal pathogens, and lack of detection of mucormycosis. Data about BDG performance for other relevant IMI, such as invasive fusariosis (IF) and invasive scedosporiosis/lomentosporiosis (IS) are scarce.

View Article and Find Full Text PDF

Resistance to fluconazole (FLC), the most widely used antifungal drug, is typically achieved by altering the azole drug target and/or drug efflux pumps. Recent reports have suggested a link between vesicular trafficking and antifungal resistance. Here, we identified novel regulators of extracellular vesicle (EV) biogenesis that impact FLC resistance.

View Article and Find Full Text PDF

A Functional Polymorphism in IL-1B Is Associated With Immune Reconstitution Inflammatory Syndrome of Chronic Disseminated Candidiasis.

Open Forum Infect Dis

March 2023

Université de Paris Cité, APHP, Service des Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Centre d'Infectiologie Necker-Pasteur, Institut Imagine, Paris, France.

We investigated single nucleotide polymorphisms (SNPs) possibly involved in immune reconstitution inflammatory syndrome of chronic disseminated candidiasis (IRIS-CDC) through a candidate gene approach and a prospective matched-control study. We found that an SNP located in interleukin-1B at rs1143627 was significantly associated with the risk of developing IRIS-CDC.

View Article and Find Full Text PDF

STAT3 mutation-associated airway epithelial defects in Job syndrome.

J Allergy Clin Immunol

August 2023

Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, Mass; Departments of Pediatrics, Harvard Medical School, Boston, Mass; Division of Pediatric Pulmonary Medicine, Massachusetts General Hospital for Children, Boston, Mass. Electronic address:

Background: Job syndrome is a disease of autosomal dominant hyper-IgE syndrome (AD-HIES). Patients harboring STAT3 mutation are particularly prone to airway remodeling and airway infections.

Objectives: Airway epithelial cells play a central role as the first line of defense against pathogenic infection and express high levels of STAT3.

View Article and Find Full Text PDF

Does F-FDG PET/CT add value to conventional imaging in clinical assessment of chronic disseminated candidiasis?

Front Med (Lausanne)

December 2022

Université de Paris Cité, APHP, Service des Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Centre d'Infectiologie Necker-Pasteur, Institut Imagine, Paris, France.

Background: Chronic disseminated candidiasis (CDC) classically occurs after profound and prolonged neutropenia. The aim of the CANHPARI study was to assess the clinical value of adding F-fluorodeoxyglucose PET/CT to conventional radiology for initial and subsequent evaluations of CDC.

Materials And Methods: A pilot prospective study was conducted in 23 French onco-hematological centers from 2013 to 2017 (NCT01916057).

View Article and Find Full Text PDF

Objectives: To determine the epidemiological cut-off values (ECVs) of ten antifungal agents in a wide range of yeasts and Aspergillus spp. using gradient concentration strips.

Methods: The minimum inhibitory concentrations for amphotericin B, anidulafungin, caspofungin, micafungin, flucytosine, fluconazole, itraconazole, isavuconazole, posaconazole, and voriconazole, determined with gradient concentration strips at 35 French microbiology laboratories between 2002 and 2020, were retrospectively collected.

View Article and Find Full Text PDF

[Invasive fungal infections in immunocompromised children in paediatric haematology: Recommendations for management in SFCE centres].

Bull Cancer

November 2022

Université-Lyon1, hospices civils de Lyon, institut d'hématologie et d'oncologie pédiatrique, faculté de médecine et de maïeutique Lyon Sud, Lyon. Electronic address:

Introduction: To date, invasive fungal infections (IFIs) are still responsible for a high mortality rate in children managed for haematological malignancy. Although Candida and Aspergillus infections remain in the majority, emerging fungal infections are increasingly common. Children differ from adults in their pathology and treatment, as well as in their prior fungal colonisation and unique pharmacokinetics.

View Article and Find Full Text PDF

Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis.

Med Mycol

October 2022

Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, F-75010 Paris, France.

Article Synopsis
  • Cryptococcal antigen (CrAg) is a marker found in the fluids of patients with cryptococcal infections, and various testing methods like CALAS and LFA are used to detect it, including commercial kits like CryptoPS and CrAg LFA.
  • In a 3-year study involving 43 serum samples, the CryptoPS test showed a high rate of false positives, indicating that patients without cryptococcal infections often tested positive, suggesting the presence of interfering substances in the serum.
  • A simple pretreatment method (incubation and centrifugation) was effective in reducing false positives, though it slightly affected the sensitivity of the test for some patients with actual cryptococcal disease.
View Article and Find Full Text PDF